ANGECON

About:

ANGECON is a biotechnology company that develops cell drugs and healthy cell storage.

Website: http://angecon.com/

Top Investors: Fudewu Sheng, Sanjie Touzi

Description:

ANGECON performs cell development, manufacturing, sales, warehousing, and service. They create new cell medicines and offer a variety of cell treatments to people suffering from long-term conditions of the central nervous system. They have established a base for cell production demonstration using their cell technologies, including cell separation and purification, culture and expansion, cryopreservation and recovery, directional induction, identification, and testing.

Total Funding Amount:

41.2M CNY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2010-02-02

Founders:

Jin Yiqiang

Number of Employees:

11-50

Last Funding Date:

2017-06-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai